https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3AGlucagon-like_peptide-1%2F21%2FenTranslations:Glucagon-like peptide-1/21/en - Revision history2026-09-14T23:19:09ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:Glucagon-like_peptide-1/21/en&diff=127248&oldid=prevFuzzyBot: Importing a new version from external source2024-03-11T00:48:14Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>In the brain, GLP-1 receptor activation has been linked with neurotrophic effects including [[neurogenesis]] and [[Neuroprotection|neuroprotective]] effects including reduced necrotic and apoptotic signaling, [[cell death]], and dysfunctions. In the diseased brain, GLP-1 receptor agonist treatment is associated with protection against a range of experimental disease models such as [[Parkinson's disease]], [[Alzheimer's disease]], stroke, [[traumatic brain injury]], and [[multiple sclerosis]]. In accordance with the expression of GLP-1 receptor on brainstem and hypothalamus, GLP-1 has been shown to promote satiety and thereby reduce food and water intake. Consequently, diabetic subjects treated with GLP-1 receptor agonists often experience weight loss as opposed to the weight gain commonly induced with other treatment agents.</div>FuzzyBot